Cancer Management and Research (Sep 2020)

Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy

  • Lu S,
  • Liu Z,
  • Zhou X,
  • Wang B,
  • Li F,
  • Ma Y,
  • Wang W,
  • Ma J,
  • Wang Y,
  • Wang H,
  • Fu W

Journal volume & issue
Vol. Volume 12
pp. 8555 – 8568

Abstract

Read online

Siyi Lu,1,* Zhenzhen Liu,1,* Xin Zhou,1 Bingyan Wang,1 Fei Li,1 Yanpeng Ma,1 Wendong Wang,1 Junren Ma,1 Yuxia Wang,2 Hao Wang,2 Wei Fu1 1Department of General Surgery, Peking University Third Hospital, Beijing 100191, People’s Republic of China; 2Department of Radiotherapy, Peking University Third Hospital, Beijing 100191, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei FuDepartment of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing 100191, People’s Republic of ChinaEmail [email protected] WangDepartment of Radiotherapy, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing 100191, People’s Republic of ChinaEmail [email protected]: Inflammatory response and nutritional status are associated with cancer development and progression. The purpose of this study was to explore whether the preoperative fibrinogen-albumin ratio index (FARI) is related to prognosis and chemoradiotherapy outcome of radical surgery after neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced rectal cancer (LARC).Methods: In total, 123 patients with LARC who underwent radical surgery after NCRT between June 2012 and December 2018 were collected in this study. Time-dependent receiver operating characteristic (ROC) curve analysis was made to evaluate the ability of the markers for forecasting prognosis. The correlation between FARI and clinicopathological parameters was analyzed. The Kaplan–Meier survival analysis, univariate and multivariate analysis based on Cox proportional hazards models, and subgroup analysis were performed to evaluate overall survival (OS) and disease-free survival (DFS). A nomogram was constructed to evaluate the predictive role of FARI in DFS.Results: The ROC curve analysis showed that the ability of FARI on DFS prediction was superior to those of other inflammatory markers and carcinoembryonic antigen (CEA) (P< 0.05). Based on the Youden’s index, the optimal cut-off value of FARI was 8.8%. High FARI patients (> 8.8%) showed a poor response to NCRT and a decreased DFS rate (P< 0.05). In addition, multivariate analysis revealed that FARI (HR=3.098, P=0.033), neutrophil-to-lymphocyte ratio (NLR), and postoperative T stage were independent prognostic factors for DFS in TNM stage III LARC patients. However, FARI failed to distinguish patients with poor OS. Harrell’s concordance index (C-index) of the nomogram containing FARI (0.807) was obviously higher than that without it (0.732) among LARC patients who underwent radical surgery after NCRT. Moreover, multivariate analysis revealed FARI (OR=3.044, P=0.012) as an independent predictor for response to NCRT.Conclusion: Among LARC patients who underwent radical surgery after NCRT, preoperative FARI is an independent prognostic factor for DFS and an independent predictor for response to NCRT.Keywords: rectal cancer, fibrinogen-albumin ratio index, prognosis, tumor regression grade

Keywords